ATP7 CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. ATP7 Gen Silencer sind erhältlich als ATP7 CRISPR/Cas9 Knockout Plasmide und ATP7 Double Nickase Plasmide. ATP7 CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
ATP7 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
ATP7A CRISPR/Cas9 KO Plasmid (h) | sc-402387 | h | Gene Knockout | GFP | 0 | ||
ATP7A HDR Plasmid (h) | sc-402387-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ATP7A Double Nickase Plasmid (h) | sc-402387-NIC | h | Gene Knockout | Puromycin | 0 | ||
ATP7A Double Nickase Plasmid (h2) | sc-402387-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ATP7A CRISPR/Cas9 KO Plasmid (m) | sc-419259 | m | Gene Knockout | GFP | 0 | ||
ATP7A HDR Plasmid (m) | sc-419259-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ATP7A Double Nickase Plasmid (m) | sc-419259-NIC | m | Gene Knockout | Puromycin | 0 | ||
ATP7A Double Nickase Plasmid (m2) | sc-419259-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ATP7B CRISPR/Cas9 KO Plasmid (h) | sc-416939 | h | Gene Knockout | GFP | 0 | ||
ATP7B HDR Plasmid (h) | sc-416939-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ATP7B Double Nickase Plasmid (h) | sc-416939-NIC | h | Gene Knockout | Puromycin | 0 | ||
ATP7B Double Nickase Plasmid (h2) | sc-416939-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ATP7B CRISPR/Cas9 KO Plasmid (m) | sc-419260 | m | Gene Knockout | GFP | 0 | ||
ATP7B HDR Plasmid (m) | sc-419260-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ATP7B Double Nickase Plasmid (m) | sc-419260-NIC | m | Gene Knockout | Puromycin | 0 | ||
ATP7B Double Nickase Plasmid (m2) | sc-419260-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ATP7 CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
ATP7A CRISPR Activation Plasmid (h) | sc-402387-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A CRISPR Activation Plasmid (h2) | sc-402387-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A Lentiviral Activation Particles (h) | sc-402387-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A Lentiviral Activation Particles (h2) | sc-402387-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A CRISPR Activation Plasmid (m) | sc-419259-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A CRISPR Activation Plasmid (m2) | sc-419259-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A Lentiviral Activation Particles (m) | sc-419259-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7A Lentiviral Activation Particles (m2) | sc-419259-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B CRISPR Activation Plasmid (h) | sc-416939-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B CRISPR Activation Plasmid (h2) | sc-416939-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B Lentiviral Activation Particles (h) | sc-416939-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B Lentiviral Activation Particles (h2) | sc-416939-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B CRISPR Activation Plasmid (m) | sc-419260-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B CRISPR Activation Plasmid (m2) | sc-419260-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B Lentiviral Activation Particles (m) | sc-419260-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ATP7B Lentiviral Activation Particles (m2) | sc-419260-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |